The journey from discovery of microRNAs to their application in medicine is challenging, with no FDA-approved drugs despite the potential for treating cancer and heart disease.
Frank Slack emphasizes, 'The promise is there. The technology is getting better. And the attention from the Nobel Prize is really good - this will drive interest again.'
Slack notes that in the 1990s, the focus was on understanding microRNAs as a new form of gene regulation; however, the realization of their medical potential shifted ambitions significantly.
Collection
[
|
...
]